This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CoolSculpting® More Accessible To Patients Through New Financing Agreement With CareCredit

ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ) – the medical technology company that developed CoolSculpting, a non-surgical, clinically proven procedure designed to selectively eliminate diet and exercise resistant fat using a patented cooling technology – today announced a new agreement with CareCredit, a leading healthcare credit card, to provide payment options to patients.

Launched nationwide, the new agreement will provide ZELTIQ’s network of more than 400 physicians the opportunity to offer their patients special financing. Even if patients have the funds available, CareCredit provides payment options for patients to build cosmetic procedures such as CoolSculpting into their monthly budget.

“Although CoolSculpting is thought to be attractively priced by consumers we speak with, this program provides payment options that patients have requested,” said Mark Foley, Interim President and Chief Executive Officer of ZELTIQ. “Thanks to this strong relationship with CareCredit, CoolSculpting will further expand the aesthetic category by providing those considering treatment with more choices on how to budget and benefit from our differentiated procedure.”

“CareCredit is a healthcare credit card that provides patients with a revolving line of credit, specifically for elective procedures like CoolSculpting,” said Tony Seymour, Senior Vice President, Sales, CareCredit. “For over 25 years, we have provided payment options that patients value and enable them to get the care they want and need for themselves and their family members. We look forward to working with CoolSculpting practices and their patients.”

CareCredit is currently accepted by over 150,000 providers. Patients can apply for CareCredit in the CoolSculpting provider’s office, online at carecredit.com, or via their mobile devices with the SmartPhone enabled application app. Cardholders and providers consistently share feedback about CareCredit’s value and ease-of-use. Results from regular surveys* of more than 1,500 cardholders confirm: more than 96 percent of cardholders say they are highly satisfied with the program and that the service meets or exceeds their expectations; more than 95 percent of both cardholders and providers consistently rate it a fair to excellent value; and more than 86 percent indicate they would recommend to a friend.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs